Presentation is loading. Please wait.

Presentation is loading. Please wait.

Corrigendum to “Antibody-targeted myofibroblast apoptosis reduces fibrosis during sustained liver injury” [J Hepatol 49 (2008) 88–98]  Angela Douglass,

Published byEmma Bakosné Modified over 5 years ago

Similar presentations

Presentation on theme: "Corrigendum to “Antibody-targeted myofibroblast apoptosis reduces fibrosis during sustained liver injury” [J Hepatol 49 (2008) 88–98]  Angela Douglass,"— Presentation transcript:

1 Corrigendum to “Antibody-targeted myofibroblast apoptosis reduces fibrosis during sustained liver injury” [J Hepatol 49 (2008) 88–98]  Angela Douglass, Karen Wallace, Rebecca Parr, Jennifer Park, Elaine Durward, Ian Broadbent, Caroline Barelle, Andrew J. Porter, Matthew C. Wright  Journal of Hepatology  Volume 52, Issue 5, (May 2010) DOI: /j.jhep Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

2 Fig. 6 Journal of Hepatology  , DOI: ( /j.jhep ) Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Download ppt "Corrigendum to “Antibody-targeted myofibroblast apoptosis reduces fibrosis during sustained liver injury” [J Hepatol 49 (2008) 88–98]  Angela Douglass,"

Similar presentations

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages 179-202 (January 2016) DOI: 10.1016/j.jhep.2015.07.040.

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.
Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 63, Issue 1, Pages (July 2015)

Volume 63, Issue 1, Pages (July 2015)
Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology 

Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology 
Volume 46, Issue 3, Pages (March 2007)

Volume 46, Issue 3, Pages (March 2007)
Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen 

Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen 
Inflammasomes in liver diseases

Inflammasomes in liver diseases
Volume 50, Issue 4, Pages (April 2009)

Volume 50, Issue 4, Pages (April 2009)
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.

Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Volume 58, Issue 2, (February 2013)

Volume 58, Issue 2, (February 2013)
Volume 58, Issue 2, (February 2013)

Volume 58, Issue 2, (February 2013)
Primary prevention of variceal haemorrhage: A pharmacological approach

Primary prevention of variceal haemorrhage: A pharmacological approach
Volume 61, Issue 6, Pages (December 2014)

Volume 61, Issue 6, Pages (December 2014)
Volume 51, Issue 6, Pages (December 2009)

Volume 51, Issue 6, Pages (December 2009)
Reactive oxygen species in the normal and acutely injured liver

Reactive oxygen species in the normal and acutely injured liver
Cédric Coulouarn, Bruno Clément  Journal of Hepatology 

Cédric Coulouarn, Bruno Clément  Journal of Hepatology 
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 

Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
NS5A inhibitors in the treatment of hepatitis C

NS5A inhibitors in the treatment of hepatitis C
Immigration and viral hepatitis

Immigration and viral hepatitis

Similar presentations

Ads by Google